Teva Pharma Industries Ltd ADR
Price & Volume
Stats
See more52W Range | $12.47-$31.99 |
Market Cap | $35.8B |
Shares Short | 44M |
Financials
See moreRevenue (12 Mos) | $16.7B |
Revenue Growth (YoY) | 3.4% |
Gross Profit (12 Mos) | $8.4B |
Diluted EPS | $0.61 |
News
See moreYahoo Finance • 9 days ago
S&P Global Ratings Upgrades Teva to ‘BB+’ Amid Strong Execution of Pivot to Growth Strategy; Moody's Ratings Agency Revises Outlook to Positive
Yahoo Finance • 10 days ago
Billionaire Stanley Druckenmiller Sold Nvidia and Palantir and Piled Into One of Wall Street's Hottest Drug Stocks Ahead of 2026
Yahoo Finance • 12 days ago
Teva Pharmaceutical Industries' (NYSE:TEVA) investors will be pleased with their impressive 228% return over the last three years
Yahoo Finance • 15 days ago
Alvotech, Teva reach settlement with Regeneron over Eylea biosimilar AVT06 in U.S.
About
CEO | Mr. Richard D. Francis |
CFO | Mr. Eliyahu Sharon Kalif |
Address | 124 Dvora HaNevi?a St., Tel Aviv-Yafo, Israel, 6944020 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 33,892 |
